$RMTG Balance Sheet | Understand Stock

$RMTG

$0.08 -$0.00 (2.2%) Close

$RMTG Overview Financial Statements SEC Filings Executives News Red Flags Capital Raising Ownership Insider Transactions Congressional Trades

Financial Statements

Income Statement Balance Sheet Cashflow Statement

Consolidated Balance Sheets

In millions of USD, except per-share amounts

	Q2 FY2026 As of Jun 30, 2026	Q1 FY2026 As of Mar 31, 2026	Q4 FY2025 As of Dec 31, 2025	Q3 FY2025 As of Sep 30, 2025	Q2 FY2025 As of Jun 30, 2025	Q1 FY2025 As of Mar 31, 2025	Q4 FY2024 As of Dec 31, 2024	Q3 FY2024 As of Sep 30, 2024	Q2 FY2024 As of Jun 30, 2024	Q1 FY2024 As of Mar 31, 2024	Q4 FY2023 As of Dec 31, 2023	Q3 FY2023 As of Sep 30, 2023	Q2 FY2023 As of Jun 30, 2023	Q1 FY2023 As of Mar 31, 2023	Q4 FY2022 As of Dec 31, 2022	Q3 FY2022 As of Sep 30, 2022	Q2 FY2022 As of Jun 30, 2022	Q1 FY2022 As of Mar 31, 2022	Q4 FY2021 As of Dec 31, 2021	Q3 FY2021 As of Sep 30, 2021
Current assets
Cash and cash equivalents
Restricted cash
Accounts receivable
Inventory
Prepaid expenses
Total current assets
Property and equipment, net
Other assets
Other assets
Intangible assets, net
Right of use asset, net
Goodwill
Total assets

Current liabilities
Liabilities held for sale
Accounts payable and accrued liabilities
Accrued interest
Stock payable – related party
Stock payable-related party
Stock payable
Due to related party
Customer advances
Derivative liability
Lease liability, current portion
Convertible notes payable, net
Notes payable-related parties
Related Party
Total notes payable-related parties

Notes payable, net
Total current liabilities

Long term liabilities
Lease liability, net of current portion
Convertible notes payable, net of current portion
Notes payable, net of current portion
Related Party
Total notes payable, net of current portion
Notes payable – related parties
Total liabilities
Stockholders’ deficit
Preferred stock, value
Series AA Preferred Stock
Series CC Preferred Stock
Series DD Preferred Stock
Total preferred stock, value

Preferred stock, $0.001 par value; 10,000 shares authorized as Series DD; 9,870 shares issued and outstanding as of March 31, 2023 and December 31, 2022, respectively
Common stock, $0.001 par value: 100,000,000 shares authorized: 13,738,968 and 13,138,968 issued and outstanding as of June 30, 2026, and December 31, 2025, respectively
Additional paid in capital
Accumulated deficit
Total stockholders’ deficit

Total liabilities and stockholders’ deficit

Comments